SPRY4 intronic transcript 1 (SPRY4-IT1), transcribed from an intron of the SPRY4 gene, has been reported to be dysregulated in various cancers including esophageal squamous cell carcinoma, breast cancer, and gastric cancer[99–101]. This evidence concerns the gene SPRY4 and gastric cancer.